Table of contents
24 August 2017
Vaccination to prevent de novo hepatitis B: Are there patients who do not need antiviral prophylaxis?
Elizabeth C. Verna – 24 August 2017
Hepatology Highlights
Robert E. Schwartz, Jennifer Batisti, Robert S. Brown, Zaid Tafesh, Nicole Shen, Nicholas Russo, Russell Rosenblatt, Emily Schonfeld, Shirley Cohen‐Mekelburg, Vikas Gupta – 24 August 2017
Megatrends in bile acid receptor research
Luciano Adorini, Kristina Schoonjans, Scott L. Friedman – 24 August 2017
Model for end‐stage liver disease exceptions: A common problem
Joel P. Wedd – 24 August 2017
Masthead
24 August 2017
Notices
24 August 2017
Engaging hepatitis C infected patients in cost‐effectiveness analyses: A literature review
T. Joseph Mattingly, Eleanor M. Perfetto, Sophia L. Johnson – 23 August 2017 – Cost‐effectiveness analyses (CEAs) of hepatitis C virus (HCV) treatment strategies have become common, but few appear to include patient engagement or the patient perspective. The objectives of the current study were to (1) identify published HCV CEA studies that include patient input and (2) derive insights on patient‐informed variable and outcome selection to build a framework for future economic analyses of HCV.